July 8, 2026 · Form 4 insider transaction
Stengone Carmine N. sold 2,500 shares of Contineum Therapeutics, Inc. at $16.00 per share, a transaction worth $40.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.